Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019
This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries. This collated information represents an important step towards understanding the priority areas for action and gaps in the national responses to the hepatitis B and C epidemics. The data also provide an important baseline to help map progress towards the WHO elimination targets and ultimately achieve the 2030 sustainable development goals.
Toolkit to support the generation of robust estimates of hepatitis C prevalence
European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices. The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.
Reorienting health systems to care for people with HIV beyond viral suppression
Safreed-Harmon, K., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., del Amo, J., Kall, M., Noori, T., Porter, K., Lazarus, J.V.
HIV among women in the WHO European Region - epidemiological trends and predictors of late diagnosis, 2009-2018
Mårdh, O., Quinten, C., Kuchukhidze, G., Seguy, N., Dara, M., Amato-Gauci, A.J., Pharris, A., On Behalf Of The Ecdc/Who Hiv Surveillance Network
Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward
Adlhoch, C., Manďáková, Z., Ethelberg, S., Epštein, J., Rimhanen-Finne, R., Figoni, J., Baylis, S.A., Faber, M., Mellou, K., Murphy, N., O'Gorman, J., Tosti, M.E., Ciccaglione, A.R., Hofhuis, A., Zaaijer, H., Lange, H., de Sousa, R., Avellón, A., Sundqvist, L., Said, B., Ijaz, S.
Surveillance systems overview for 2018
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2018.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Presentation: Situation overview on hepatitis E in the EU/EEA Member States
Hepatitis E is one of the most common causes of acute hepatitis in the EU/EEA but currently not notifiable at EU level. This presentation summarises ECDC's work on the topic and survey results on hepatitis E on 2005 to 2015 data.
Hepatitis B - Annual Epidemiological Report for 2017
In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population.